ResMed

Resmed helps people with breathing problems sleep and live better. It makes medical machines and masks for patients to use at home. The company also builds software for caregivers to track health data.

The Breathing and Software Mix

• Sleep and Breathing Health: Devices, masks, and diagnostic tools for sleep apnea and respiratory care; generated $1.3 billion in revenue for Q2 2026.
• Residential Care Software: Business management platforms and cloud-based services for out-of-hospital providers; contributed $166.9 million in revenue for Q2 2026.
• Masks and Accessories: Patient interfaces and headgear for therapy systems; accounts for 37% of total revenue as of December 31, 2025.
• Cloud-Based Applications: Digital tools like AirView and myAir that allow doctors and patients to monitor therapy remotely.

Expanding the Care Network

• Maintains a global footprint with sales and distribution operations across approximately 140 countries.
• Operates specialized software subsidiaries including Brightree, MatrixCare, and HEALTHCAREfirst to serve home health and hospice agencies.
• Launched the AirSense 11 device featuring digital touch screens and over-the-air update capabilities for better patient engagement.
• Acquired Propeller to integrate digital health solutions into respiratory care management.

What Makes Resmed Stand Out

The company combines physical medical hardware with a large-scale software ecosystem to improve patient compliance and health outcomes. This connected care strategy links millions of devices to the cloud, allowing healthcare providers to manage chronic diseases more efficiently.

Key Financial Facts

• Net revenue grew to $1.4 billion in Q2 2026, an 11% increase from the prior year.
• Operating income reached $497.6 million in Q2 2026, up 19.3% from $417.2 million in Q2 2025.
• Net income rose to $392.6 million for the quarter ended December 31, 2025, a 13.9% year-over-year gain.
• Free cash flow was $311.2 million in Q2 2026, representing a 7.4% increase from $289.7 million.
• Gross profit climbed 17.8% to $884.7 million in Q2 2026 compared to $751.3 million a year earlier.

The Evolution of Care

Resmed has transitioned from a medical equipment manufacturer into a data-driven health technology firm. Its focus on cloud-connected devices and out-of-hospital software continues to define its position in the respiratory health market.